Artemis Bio-Solutions – Trademark Portfolio
Entity Type: 16
Artemis Bio-Solutions holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BIO-OXYGEN and MANY THREATS. ONE SOLUTION.. The owner is based in Elmhurst, IL.
960 North Industrial Drive
Elmhurst, IL 60126
Showing of trademarks Trademarks
Trademark Classifications
Artemis Bio-Solutions's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Artemis Bio-Solutions have?
Artemis Bio-Solutions has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Artemis Bio-Solutions file in?
Artemis Bio-Solutions files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Artemis Bio-Solutions's most well-known trademarks?
Artemis Bio-Solutions's registered trademark portfolio includes well-known marks such as BIO-OXYGEN and MANY THREATS. ONE SOLUTION.. These are among 2 currently registered trademarks in the portfolio.
What is Artemis Bio-Solutions's trademark registration success rate?
Artemis Bio-Solutions has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.